Study Summary
The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in patients with MUC1 positive relapsed or refractory solid tumor.
Want to learn more about this trial?
Request More InfoInterventions
anti-MUC1 CAR-T cellsBIOLOGICAL
No description available.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| PersonGen Biomedicine (Suzhou) Co., Ltd. | Suzhou | Jiangsu | China |